Strs Ohio Makes New Investment in Addus HomeCare Corporation $ADUS

Strs Ohio bought a new position in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The firm bought 6,600 shares of the company's stock, valued at approximately $653,000.

Several other large investors also recently added to or reduced their stakes in the business. Nuveen LLC purchased a new position in Addus HomeCare during the first quarter worth $16,155,000. GAMMA Investing LLC increased its holdings in Addus HomeCare by 10,307.8% in the 1st quarter. GAMMA Investing LLC now owns 130,930 shares of the company's stock worth $12,948,000 after acquiring an additional 129,672 shares in the last quarter. Wellington Management Group LLP grew its position in shares of Addus HomeCare by 25.8% in the first quarter. Wellington Management Group LLP now owns 471,935 shares of the company's stock valued at $46,670,000 after purchasing an additional 96,823 shares in the last quarter. Allianz Asset Management GmbH boosted its stake in Addus HomeCare by 1,229.4% during the first quarter. Allianz Asset Management GmbH now owns 100,898 shares of the company's stock worth $9,978,000 after buying an additional 93,308 shares during the period. Finally, Principal Financial Group Inc. boosted its stake in shares of Addus HomeCare by 18.3% in the 1st quarter. Principal Financial Group Inc. now owns 475,818 shares of the company's stock valued at $47,054,000 after buying an additional 73,720 shares during the period. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Trading Up 1.9%

ADUS stock opened at $111.90 on Friday. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.74 and a quick ratio of 1.74. Addus HomeCare Corporation has a 1-year low of $88.96 and a 1-year high of $136.72. The business has a 50 day simple moving average of $111.72 and a two-hundred day simple moving average of $107.70. The company has a market capitalization of $2.06 billion, a price-to-earnings ratio of 24.70, a PEG ratio of 1.70 and a beta of 0.85.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.45 by $0.04. The company had revenue of $349.44 million for the quarter, compared to the consensus estimate of $345.71 million. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The firm's revenue was up 21.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.35 EPS. Research analysts anticipate that Addus HomeCare Corporation will post 4.59 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have commented on the company. Stephens reaffirmed an "overweight" rating and set a $140.00 price objective on shares of Addus HomeCare in a research note on Wednesday, September 3rd. Barclays boosted their price objective on Addus HomeCare from $83.00 to $109.00 and gave the stock an "underweight" rating in a research note on Tuesday, August 19th. TD Cowen upped their price objective on Addus HomeCare from $135.00 to $139.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. Macquarie reiterated an "outperform" rating and set a $133.00 price objective on shares of Addus HomeCare in a research note on Tuesday, June 10th. Finally, UBS Group initiated coverage on shares of Addus HomeCare in a research report on Tuesday, September 2nd. They issued a "buy" rating and a $145.00 price target on the stock. Two investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of $138.89.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, Director Veronica Hill-Milbourne sold 1,571 shares of the firm's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $114.93, for a total transaction of $180,555.03. Following the sale, the director owned 5,067 shares of the company's stock, valued at approximately $582,350.31. This trade represents a 23.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Brian Poff sold 7,739 shares of the business's stock in a transaction on Monday, August 25th. The stock was sold at an average price of $116.82, for a total transaction of $904,069.98. Following the sale, the executive vice president owned 56,980 shares in the company, valued at $6,656,403.60. The trade was a 11.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 34,310 shares of company stock valued at $3,958,375 in the last three months. 4.50% of the stock is currently owned by company insiders.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.